Senior Vice President, Business Development and Licensing, Merck Research Laboratories
Ben is Senior Vice President, BD&L and Head of North American Innovation Hubs at Merck Research Laboratories. As such, Ben leads the Boston Innovation Hub and the West Coast Innovation Hub, each of which is a full business development organization, tasked with bringing new molecules, technologies and collaborations into Merck, especially in the New England and West Coast Regions. The emphasis for these activities is on early-stage (prior to PoC in Humans) opportunities. The Innovation Hubs work closely with academic centers, biotech and pharma companies.
Prior to joining Merck, Ben was Head of Transactions in Strategic Alliances at Novartis Institutes for BioMedical Research (NIBR). In this role, Ben led a group of professional negotiators to value and structure deals and to drive cross-functional deal teams to close deals between NIBR (Novartis’ organization responsible for Research and Early Development) and potential partners. These deals ranged from research collaborations, to licensing deals to IP acquisitions and the like. NIBR’s partners include biotechnology companies and academic partners.
Prior to joining Novartis, Ben led the execution of numerous deals as Executive Director of Licensing at Amgen. Ben also held other roles at Amgen, including Senior Counsel in Amgen’s legal department, where he drafted and negotiated key licensing and related deals.
Before moving in-house, Ben worked as an attorney in private practice at the law firm of Brobeck, Phleger & Harrison LLP, spending several years in the firm’s offices in New York City and in the Boulder/Denver area of Colorado. Ben also served as a law clerk to the Honorable Judge Randall R. Rader on the US Court of Appeals for the Federal Circuit in Washington DC.
Ben holds a Masters Degree in Biology and a JD from the University of Virginia and an undergraduate degree in Government & Politics from George Mason University.